“Jardiance 10 mg”的搜索结果，显示 151-160 项，共有 3405 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to see if different depths of submucosal tumor invasion in esophageal cancer can predict lymph node involvement ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to collect vaginal and endometrial cell samples to study ...

3. 皮肤科- 临床试验- 妙佑医疗国际

   The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Cohort C: Triple-negative breast cancer (TNBC);; Cohort D: Platinum-resistant/refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer ( ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the association between a baseline comprehensive geriatric assessment (cGA) and chemotherapy toxicity in the first ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purposes of this study are to collect prostate surgical samples from metastatic patients to establish xenograft tumor lines for future testing of ...

7. 妙佑医疗国际移植中心- 临床试验

   20 patients will be treated with imlifidase and 10 with PE. APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO). Scottsdale/Phoenix, Ariz. The ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn., Jacksonville, Fla., Albert Lea, Minn. The puporse of this trial is to compare less intense hormone therapy and radiation therapy to usual ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is a prospective, pilot, single arm study to evaluate the incidence of IIC in patients with solid malignancies receiving VSL#3 and ICIs.

10. 血液科- 临床试验- 妙佑医疗国际

    ... (10) advanced, unresectable multiple myeloma. Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with ...